Oxford Glycosciences to Buy Applied Biosystems Mass Spectrometers, Develop Biochips with Packard | GenomeWeb

PARIS, Sept 19 – Britain’s Oxford Glycosciences (LSE: OGS) announced on Tuesday a deal to buy next generation mass spectrometers from Applied Biosystems (NYSE: PEB) as well as an agreement to collaborate with Packard BioScience (Nasdaq: PBSC) to develop protein biochips.

Financial terms of the deals, which represent significant efforts to secure a leading position in the proteomics sector, were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.